Recent Finacing
Recent Raise
SpringLeaf Therapeutics develops a prefilled morphing-surface delivery platform to enable subcutaneous self-administration of highly viscous, large-volume biologic therapeutics, reducing multiple injections and complex devices.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors